A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.

OXFORD, England, February 05, 2025--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...

Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...

OXFORD, England, February 05, 2025--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Colon cancer is one of the most prevalent cancers globally, especially among adults over 45. Crucial in prevention and early detection, maintaining a healthy diet and consuming gut-friendly drinks ...

Radwah Oda was just 30 when she was diagnosed with colon cancer, an illness that seemed to come out of the blue. But looking back, she’d been experiencing symptoms for about a year without ...

Radwah Oda was just 30 when she was diagnosed with colon cancer, an illness that seemed to come out of the blue. But looking back, she’d been experiencing symptoms for about a year without ...